Left ventricular diastolic function in patients with type 2 diabetes treated with a dipeptidyl peptidase-4 inhibitor- a pilot study

BACKGROUND: Blood glucose control is fundamental albeit not enough to prevent diabetic macrovascular complications. Dipeptidyl peptidase-4 (DPP-4) inhibitors are effective in improving metabolic parameters in patients with type 2 diabetes mellitus (T2DM) but little is known about its cardiovascular...

Descripción completa

Detalles Bibliográficos
Autores principales: Nogueira, Katia Camarano, Furtado, Meive, Fukui, Rosa Tsuneshiro, Correia, Marcia Regina Silva, dos Santos, Rosa Ferreira, Andrade, José Lázaro, Rossi da Silva, Maria Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183768/
https://www.ncbi.nlm.nih.gov/pubmed/25285158
http://dx.doi.org/10.1186/1758-5996-6-103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183768/
https://www.ncbi.nlm.nih.gov/pubmed/25285158
http://dx.doi.org/10.1186/1758-5996-6-103

Ejemplares similares